Loading...
XSTOERMA
Market cap15mUSD
Dec 23, Last price  
3.06SEK
1D
-6.99%
1Q
-38.06%
Jan 2017
-65.24%
IPO
-59.37%
Name

Enorama Pharma AB

Chart & Performance

D1W1MN
XSTO:ERMA chart
P/E
—
P/S
129.92
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
39.20%
Rev. gr., 5y
-23.71%
Revenues
1m
-80.17%
1,383,2431,993,7783,991,2041,572,8905,256,0117,610,7172,146,00011,036,0006,847,0001,358,000
Net income
-45m
L+6.78%
-20,000-656,000-7,836,114-8,755,754-16,339,339-24,721,571-23,901,000-28,544,000-41,780,000-44,613,000
CFO
-41m
L+25.46%
307,000480,000-6,114,487-6,666,545-13,360,169-26,563,507-22,998,000-30,164,000-32,958,000-41,349,000

Profile

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company is based in Malmö, Sweden.
URL
https://www.enorama.se/
IPO date
Jun 10, 2016
Employees
9
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,358
-80.17%
6,847
-37.96%
11,036
414.26%
Cost of revenue
8,130
10,335
24,994
Unusual Expense (Income)
NOPBT
(6,772)
(3,488)
(13,958)
NOPBT Margin
Operating Taxes
(250)
802
Tax Rate
NOPAT
(6,772)
(3,238)
(14,760)
Net income
(44,613)
6.78%
(41,780)
46.37%
(28,544)
19.43%
Dividends
Dividend yield
Proceeds from repurchase of equity
43,126
9,000
43,214
BB yield
-50.23%
-25.99%
-25.84%
Debt
Debt current
133
1,464
2,088
Long-term debt
303
445
1,701
Deferred revenue
Other long-term liabilities
4,326
4,326
16,200
Net debt
(5,717)
(2,230)
(8,411)
Cash flow
Cash from operating activities
(41,349)
(32,958)
(30,164)
CAPEX
(1,823)
Cash from investing activities
(1,823)
Cash from financing activities
41,863
25,345
39,508
FCF
(6,095)
(1,936)
(18,622)
Balance
Cash
6,153
4,139
12,200
Long term investments
Excess cash
6,085
3,797
11,648
Stockholders' equity
(185,783)
(142,448)
(105,092)
Invested Capital
210,083
179,779
146,046
ROIC
ROCE
EV
Common stock shares outstanding
27,696
9,488
7,517
Price
3.10
-15.07%
3.65
-83.60%
22.25
-32.78%
Market cap
85,859
147.92%
34,632
-79.29%
167,246
-25.09%
EV
80,142
32,402
158,835
EBITDA
(3,224)
49
(12,577)
EV/EBITDA
661.27
Interest
883
1,273
802
Interest/NOPBT